A novel regulatory element between the human FGA and FGG genes

Thrombosis and Haemostasis

Volumn 108, Issue 3, 2012, Pages 427-434

  Fish, Richard J ^a   Neerman Arbez, Marguerite ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Department of Surgery   (Switzerland)

Author keywords

Enhancer; Fibrinogen; Gene regulation; Regulatory element

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RISK; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; FGA GENE; FGG GENE; FIBRINOGEN BLOOD LEVEL; GENE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; REPORTER GENE; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME MAPPING; CONSERVED SEQUENCE; ENHANCER ELEMENTS, GENETIC; FIBRINOGEN; GENE EXPRESSION REGULATION; GENES, REPORTER; GENES, SYNTHETIC; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HEP G2 CELLS; HEPATOCYTES; HUMANS; LARVA; LIVER NEOPLASMS; LUCIFERASES; MICE; RECOMBINANT FUSION PROTEINS; TRANSGENES; ZEBRAFISH;

EID: 84865821493     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-04-0274     Document Type: Article

References (29)

1. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-1809.
2. de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010; 36: 7-17.
3. Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol 2011; 73: 503-514.
4. Machlus KR, Cardenas JC, Church FC, et al. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 2011; 117: 4953-4963.
5. Ariens RA. Elevated fibrinogen causes thrombosis. Blood 2011; 117: 4687-4688.
6. Otto JM, Grenett HE, Fuller GM. The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone. J Cell Biol 1987; 105: 1067-1072.
7. Fuller GM, Zhang Z. Transcriptional control mechanism of fibrinogen gene expression. Ann NY Acad Sci 2001; 936: 469-479.
8. Fort A, Borel C, Migliavacca E, et al. Regulation of fibrinogen production by microRNAs. Blood 2010; 116: 2608-2615.
9. Humphries SE, Ye S, Talmud P, et al. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995; 15: 96-104.
10. Prabhakar S, Poulin F, Shoukry M, et al. Close sequence comparisons are sufficient to identify human cis-regulatory elements. Genome Res 2006; 16: 855-863.
11. Pennacchio LA, Ahituv N, Moses AM, et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature 2006; 444: 499-502.
12. Visel A, Blow MJ, Li Z, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457: 854-858.
13. Fort A, Fish RJ, Attanasio C, et al. A liver enhancer in the fibrinogen gene cluster. Blood 2011; 117: 276-282.
14. Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011; 144: 327-339.
15. Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissuespecific gene expression. Nat Rev Genet 2011; 12: 283-293.
16. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
17. Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816.
18. Blanchette M, Kent WJ, Riemer C, et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 2004; 14: 708-715.
19. Siepel A, Bejerano G, Pedersen JS, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005; 15: 1034-1050.
20. Fish RJ, Vorjohann S, Bena F, et al. Developmental expression and organisation of fibrinogen genes in the zebrafish. Thromb Haemost 2012; 107: 158-166.
21. Cullen KE, Kladde MP, Seyfred MA. Interaction between transcription regulatory regions of prolactin chromatin. Science 1993; 261: 203-206.
22. Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002; 295: 1306-1311.
23. de Wit E, de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev 2012; 26: 11-24.
24. Dehghan A, Yang Q, Peters A, et al. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2009; 2: 125-133.
25. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9.
26. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
27. Ridker PM, Vaughan DE, Stampfer MJ, et al. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
28. de Lange M, Snieder H, Ariens RA, et al. The genetics of haemostasis: a twin study. Lancet 2001; 357: 101-105.
29. Fish RJ, Neerman-Arbez M. Fibrinogen gene regulation. Thromb Haemost 2012; 108: 419-426.